Global Biopharmaceutical Company - Bristol Myers Squibb
During Global Patient Week, our CEO shares his thoughts on how the culture of putting patients first is an integral part of everything we do.
Through our robust global patient advocacy programs, we listen to experts, advocates and, most importantly, our patients to weave their experiences into everything we do.
For this year’s Global Patient Week, our Executive Vice President, Global Product Development & Supply, shares her thoughts on how the manufacturing work her team does impacts lives around the world.
Bristol Myers Squibb is continuing to examine the immune system from multiple perspectives in order to find complementary combinations of therapies that have the potential to improve outcomes for patients.
Learn about how the company aims to build a robust immunology portfolio with pathbreaking science that addresses the unmet needs of people living with immune-mediated diseases.
Bristol Myers Squibb leaders share the latest in the field. Learn how Bristol Myers Squibb is advancing research to explore the potential of cell therapy for treatment of various cancers.
Global Patient Week
Now in its eighth year, Global Patient Week is an essential part of our culture — it unifies us and reignites our passion to do more for our patients. As the first biopharma to set aside time solely focused on the individuals we are working for each and every day, Global Patient Week is a pinnacle of our year-round vision to transform patients’ lives through science.
Lorena lives with lung cancer and was told she only had six months to live. Hear about her journey and her fight for healing.
2021 GLOBAL INCLUSION & DIVERSITY
Leading with our Value of Inclusion
Moving forward. Together.
Looking for answers?
Quick links to helpful resources.
What we are talking about on Twitter
Our company’s legacy of innovation began in the early 1800s, when our founders made it their mission to bring better health solutions to patients who needed them most. Today, we are continuing that tradition by using the latest science and technology to help improve lives through the research and development of new medicines for serious diseases.